Polio Vaccine: Why Multiple Doses Are Necessary

does the polio vaccine have to be administered multiple times

The polio vaccine, which prevents poliomyelitis (polio), has been administered to children as part of their routine immunizations for decades. There are two types of vaccines: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends that all children be fully vaccinated against polio. While the number of cases has decreased from 350,000 in 1988 to 33 in 2018, does this mean that the polio vaccine has to be administered multiple times?

Characteristics Values
Number of doses 4 doses for children, 3 doses for adults
Age Children and adults
Administration Injected into the leg or arm, or by drops in the mouth
Intervals between doses 4-8 weeks
Time to immunity 90% or more of recipients are immune after 2 doses
Protection 99% immune after 3 doses
Protection period Immunity is probably lifelong
Side effects Mild redness or pain at the site of injection
Adverse effects 1 in every 2.7 million doses results in vaccine-associated paralytic poliomyelitis (VAPP)
Combination with other vaccines Can be given at the same time as other vaccines
Vaccination status Documentation of vaccination is required to be considered fully vaccinated

cyvaccine

Children should receive four doses of the polio vaccine

The polio vaccine, or poliomyelitis, is a safe and effective way to prevent polio. While there is no cure for polio, vaccination has been part of the routine childhood immunisation schedule in the United States for decades, and wild poliovirus has been eliminated in the country. The CDC recommends that children get four doses of the polio vaccine to protect them against severe polio disease, including paralysis. This is because 90% or more of vaccine recipients are immune after two doses, and at least 99% are immune after three doses.

The four doses of the polio vaccine are given at different ages, with the first dose being administered as early as six weeks of age. The second dose is typically given at least four weeks after the first dose, and the third dose is given at least six months after the second. If a child is delayed in getting all the recommended doses, they should finish their series by following the recommended catch-up schedule. This may include an accelerated schedule if the child is travelling to a country with a high risk of polio.

The polio vaccine can be given as an inactivated poliovirus (IPV) or a weakened poliovirus (oral polio vaccine, OPV). IPV is given by injection in the leg or arm, depending on the person's age, while OPV is given by drops in the mouth. IPV is the only polio vaccine that has been given in the United States since 2000 as it eliminates the risk of polio variants that can occur with OPV. It is also safe to administer to immunocompromised individuals and those in close contact with them.

In countries with high levels of immunisation coverage and low risks of importation and transmission, the WHO recommends a primary series of three IPV injections, with a booster dose after an interval of six months or more if the first dose was given before two months of age. However, in countries with endemic polio or a high risk of imported cases, the recommendation is to give the OPV vaccine at birth, followed by a primary series of three OPV doses and at least one IPV dose starting at six weeks of age.

cyvaccine

The polio vaccine is safe for pregnant people and those with HIV/AIDS

The polio vaccine is generally administered multiple times to ensure full protection. The CDC recommends that children receive 4 doses of the polio vaccine as part of their routine immunizations. These are given at specific age intervals, with the first dose as early as 6 weeks of age. Adults who have not been vaccinated previously should receive 3 doses of the vaccine. In certain circumstances, such as accelerated protection needs, the schedule may be adjusted, but the recommended intervals should be followed whenever possible.

Now, addressing the safety of the polio vaccine for pregnant people and those with HIV/AIDS:

The polio vaccine, specifically the inactivated polio vaccine (IPV), is considered safe for pregnant women. While it is generally advised to avoid giving the vaccine during pregnancy if there is not an increased risk of infection, IPV can be administered if a pregnant woman is at higher risk of exposure to poliovirus. This is because IPV is the only polio vaccine recommended for people with immunodeficiencies, and it might provide some protection. Studies have shown that oral polio vaccination does not increase pregnancy complications and is a safe option for pregnant women. However, the live attenuated oral polio vaccine (OPV) is not recommended during pregnancy.

Regarding the safety of the polio vaccine for people with HIV/AIDS, there have been misconceptions and conspiracy theories alleging a link between the oral polio vaccine (OPV) and HIV. These claims, popularized by journalist Edward Hooper in his book "The River: A Journey to the Source of HIV and AIDS," suggested that the vaccine was made using chimpanzee kidney cells infected with Simian Immunodeficiency Virus. However, these claims have been thoroughly debunked and are not supported by evidence. Independent laboratory examinations found that the polio vaccine in question was made using monkey cells, not chimpanzee cells, and was not contaminated with HIV or SIV. Additionally, epidemiological and genetic studies further contradicted the alleged link between OPV and HIV. Therefore, it is important to emphasize that the polio vaccine is safe for people with HIV/AIDS, and the rumors of an OPV-HIV connection are unfounded.

cyvaccine

The polio vaccine has been part of routine childhood immunisation in the US for decades

The first successful polio vaccine was created in the early 1950s by US physician Jonas Salk. Salk tested his experimental killed-virus vaccine on himself and his family in 1953, and a year later on 1.6 million children in Canada, Finland and the USA. The results were announced on 12 April 1955, and Salk’s inactivated polio vaccine (IPV) was licensed on the same day. By 1957, annual cases in the US had dropped from 58,000 to 5,600, and by 1961, only 161 cases remained.

The inactivated polio vaccine (IPV) is the only polio vaccine that has been administered in the US since 2000. It is given by injection in the leg or arm, depending on the patient's age. Children get four doses of IPV, with one dose at each of several age milestones. The CDC recommends that children in the US receive IPV to protect against polio as part of their routine immunisations. IPV may sometimes be given in the same shot as other vaccines (also known as combination vaccines).

Oral polio vaccine (OPV) is used in other countries. In April 2016, all countries that were still using OPV stopped using trivalent OPV (tOPV) and switched to using bivalent OPV (bOPV) in routine immunisation. If a person only received bOPV, they are not vaccinated against type 2 poliovirus and need to complete an IPV 3- or 4-dose series depending on their age to be fully protected.

cyvaccine

The polio vaccine has eliminated polio from most of the world

The polio vaccine has been a remarkable success story, with the wild poliovirus eliminated in all but two countries: Afghanistan and Pakistan. India eliminated polio transmission within the country by 2014, and by 2000, the Western Pacific was polio-free. This success is due to the development and distribution of two types of vaccines: the oral poliovirus vaccine (OPV) and the inactivated poliovirus vaccine (IPV).

OPV, developed by Albert Sabin, is given by drops in the mouth and has been instrumental in interrupting the chain of transmission. Its ease of administration made it ideal for mass vaccination campaigns. Hungary and Czechoslovakia were the first countries to use it in 1959 and early 1960, respectively, becoming the first countries in the world to eliminate polio. In 1962, Cuba followed suit with nationwide OPV immunization programs.

IPV, developed by Jonas Salk and licensed in 1955, is administered by injection in the leg or arm, depending on the person's age. While IPV protected the vaccinated individual, it did not stop the poliovirus from spreading between people. However, it is the only polio vaccine that has been given in the United States since 2000 to eliminate the risk of polio variants associated with OPV.

In the United States, children receive four doses of IPV as part of their routine immunizations, with one dose recommended at each of several ages. The CDC recommends that children who have not started their polio vaccine series or who are delayed in getting their recommended doses follow a catch-up schedule. For adults who have never been vaccinated against polio, three doses of IPV are recommended.

The global effort to eradicate polio has been a collaborative endeavor. The Global Polio Eradication Initiative (GPEI) has set forth a strategy with two primary goals: to permanently stop the spread of wild poliovirus and to prevent outbreaks of variant poliovirus. Success in these endeavors will ensure that no more children suffer from the devastating effects of polio.

cyvaccine

The polio vaccine is administered via injection or by mouth

The polio vaccine is typically administered via injection or by mouth, depending on the type of vaccine. The two types of polio vaccine are the inactivated polio vaccine (IPV) and the poliovirus vaccine live oral (OPV).

IPV is given by injection into the muscle or under the skin, using a needle length appropriate for the age and size of the person receiving the vaccine. It is typically injected into the deltoid muscle in the arm or the leg, depending on the person's age. The recommended dose for both children and adults is 0.5 mL, and it is usually given in four doses at specific age intervals. The first dose can be given to infants as young as 6 weeks old, but not before, as the antibodies they received from their mothers before birth may interfere with the vaccine's effectiveness.

OPV, on the other hand, is administered orally, with children receiving doses by drops into the mouth. OPV is used in countries outside the United States, as it carries a risk of polio variants that IPV does not. Since 2000, only IPV has been used in the US to eliminate this risk.

Both vaccines are safe and effective in preventing poliomyelitis (polio), and IPV can be given at the same time as other vaccines with no known risks. The number of doses required for full protection may vary depending on age and vaccination history. It is recommended to consult with a healthcare professional to determine the appropriate vaccination schedule.

Frequently asked questions

The polio vaccine is administered in a series of doses. The number of doses depends on the age of the recipient and the type of vaccine. Children in the United States receive four doses of the inactivated poliovirus vaccine (IPV) as part of their routine immunizations. Adults requiring a primary polio vaccination series should receive two doses of IPV, with a third dose coming 6-12 months after the second.

Multiple doses of the polio vaccine are necessary to ensure full protection against the poliovirus. While two doses of the vaccine are sufficient to confer immunity in 90% of recipients, three doses are required to achieve a 99% immunity rate.

Yes, there are two types of polio vaccines: inactivated poliovirus (IPV) and weakened/oral poliovirus (OPV). IPV is administered via injection, while OPV is given by mouth. IPV is the only polio vaccine that has been used in the United States since 2000 due to its safety and effectiveness in eliminating the risk of polio variants associated with OPV.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment